www.fdanews.com/articles/108485-biocryst-begins-phase-ii-study-for-treatment-of-seasonal-influenza

BioCryst Begins Phase II Study for Treatment of Seasonal Influenza

July 11, 2008

BioCryst Pharmaceuticals announced the initiation of a Phase II study of intramuscular (i.m.) peramivir for the treatment of seasonal influenza.
Fox Business